Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

03/02/2023 04:30

Feb 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             55.57               57.71            73.50    
                 (-3.7 pct)          (+1.1 pct)       (-3.3 pct)  
  Operating         12.39               13.89             7.50    
                 (-10.8 pct)         (-7.1 pct)       (-56.0 pct) 
  Recurring         12.98               14.32             8.10    
                 (-9.4 pct)          (-6.7 pct)       (-53.8 pct) 
  Net                9.15               10.25             6.10    
                 (-10.7 pct)         (-6.3 pct)       (-36.1 pct) 
  EPS            243.31 yen          269.41 yen       162.22 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T